Autoimmune Diseases  >>  remtolumab (ABT-122)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
remtolumab (ABT-122) / AbbVie
NCT01853033: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis

Completed
1
19
US
ABT-122, Placebo
AbbVie
Rheumatoid Arthritis
05/14
05/14

Download Options